In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review

• Päätekijät: Blackmore Stuart (Tekijä), Gillard Samantha (Tekijä), Brown Adam P (Tekijä), Trew Geoffrey H (Tekijä), Clewlow Christine (Tekijä), O'Donohoe Paul (Tekijä), Wasiak Radoslaw (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2010-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Previous studies have reported conflicting results for the comparative doses of recombinant follicle stimulating hormone (rFSH) and highly purified human menopausal gonadotrophin (hMG-HP) required per cycle of <it>in vitro <...